Literature DB >> 2572320

Assignment of common allele loss in osteosarcoma to the subregion 17p13.

J Toguchida1, K Ishizaki, Y Nakamura, M S Sasaki, M Ikenaga, M Kato, M Sugimoto, Y Kotoura, T Yamamuro.   

Abstract

Human osteosarcomas frequently show loss of alleles on chromosome 17 as well as those on chromosome 13 that harbors the retinoblastoma gene, indicating concerted operation of another tumor-suppressing gene on chromosome 17. To assign the affected gene to a defined region of chromosome 17, we performed mitotic recombination/deletion mapping by the use of 10 polymorphic loci on chromosome 17. Of 37 tumors studied, 28 (75.7%) showed loss of heterozygosity on chromosome 17. The affected regions varied among tumors, ranging in extent from a whole chromosome to a distal segment of the short arm. However, allele loss in one region, notably in 17p13 between D17S1 and D17S30, was common to all 28 tumors, suggesting the presence of a tumor-suppressing gene in this defined region.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2572320

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Alterations of the p53, Rb and MDM2 genes in osteosarcoma.

Authors:  C W Miller; A Aslo; A Won; M Tan; B Lampkin; H P Koeffler
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Allelic Losses from Chromosome 17 in Human Osteosarcomas.

Authors:  Marianna Sztán; Zsuzsa Pápai; Miklós Szendrôi; Marco van der Looij; Edith Oláh
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

3.  Mechanisms of p53 loss in human sarcomas.

Authors:  L M Mulligan; G J Matlashewski; H J Scrable; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 4.  Hepatitis B virus infection and primary hepatocellular carcinoma.

Authors:  M Feitelson
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

5.  Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone.

Authors:  Y Ueda; B Dockhorn-Dworniczak; S Blasius; W Mellin; P Wuisman; W Böcker; A Roessner
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

6.  Human breast cancer: frequent p53 allele loss and protein overexpression.

Authors:  S Singh; M Simon; I Meybohm; I Jantke; W Jonat; H Maass; H W Goedde
Journal:  Hum Genet       Date:  1993-02       Impact factor: 4.132

7.  Rapid detection of loss of heterozygosity of chromosome 17p by polymerase chain reaction-based variable number of tandem repeat analysis and detection of single-strand conformation polymorphism of intragenic p53 polymorphisms.

Authors:  B Dockhorn-Dworniczak; C Poremba; R Dantcheva; A Stücker; E Brömmelkamp; S Blasius; W Mellin; A Roessner; D W Yandell; W Böcker
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

8.  Inactivation of p53 gene in human and murine osteosarcoma cells.

Authors:  N Chandar; B Billig; J McMaster; J Novak
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

9.  Cervical carcinoma: low frequency of allele loss at loci implicated in other common malignancies.

Authors:  R M Busby-Earle; C M Steel; C C Bird
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

10.  PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumour tissue.

Authors:  N A Gruis; E C Abeln; A F Bardoel; P Devilee; R R Frants; C J Cornelisse
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.